UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus—Coinfected Patients With Compensated Cirrhosis

Clinical infectious diseases, 2013-06, Vol.56 (11), p.1646-1653

2013

Volltextzugriff (PDF)

Natural History of Compensated Hepatitis C Virus-Related Cirrhosis in HIV-Infected Patients

Clinical infectious diseases, 2009-10, Vol.49 (8), p.1274-1282

2009

Volltextzugriff (PDF)

Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients

AIDS (London), 2012-08, Vol.26 (13), p.1721-1724

2012

Volltextzugriff (PDF)

Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy

Clinical infectious diseases, 2013-11, Vol.57 (10), p.1401-1408

2013

Volltextzugriff (PDF)

Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients

AIDS (London), 2008-05, Vol.22 (8), p.923-930

2008

Volltextzugriff (PDF)

Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus–Coinfected Patients With Compensated Liver Cirrhosis

Clinical infectious diseases, 2012-12, Vol.55 (12), p.1719-1726

2012

Volltextzugriff (PDF)

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients

AIDS (London), 2013-10, Vol.27 (16), p.2541-2549

2013

Volltextzugriff (PDF)

Response to: Reply to: Anti-CD4 autoantibodies in immunological nonresponder people living with HIV: cause of CD4+ T cell depletion?

AIDS (London), 2023-03, Vol.37 (3), p.554-555

2023

Volltextzugriff (PDF)

Comparison of Two Methods for the Assessment of Delayed-Type Hypersensitivity Skin Responses in Patients with Human Immunodeficiency Virus Infection

Clinical infectious diseases, 1998-06, Vol.26 (6), p.1330-1334

1998

Volltextzugriff (PDF)

Increased Regulatory T Cell Counts in HIV-Infected Nonresponders to Hepatitis B Virus Vaccine

The Journal of infectious diseases, 2010-08, Vol.202 (3), p.362-369

2010

Volltextzugriff (PDF)

Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program

Diseases of the colon & rectum, 2022-01, Vol.65 (1), p.28-39

2022

Volltextzugriff (PDF)

Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients

The Journal of infectious diseases, 2018-07, Vol.218 (4), p.624-632

2018

Volltextzugriff (PDF)

Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial

Annals of internal medicine, 2009-08, Vol.151 (3), p.149

2009

Volltextzugriff (PDF)

Anti-CD4 autoantibodies in immunological nonresponder people with HIV: cause of CD4 + T-cell depletion?

AIDS (London), 2022-07, Vol.36 (9), p.1207-1214

2022

Volltextzugriff (PDF)

High-risk Human Papilloma Virus Testing Improves Diagnostic Performance to Predict Moderate- to High-grade Anal Intraepithelial Neoplasia in Human Immunodeficiency Virus–infected Men Who Have Sex With Men in Low-to-Absent Cytological Abnormalities

Clinical infectious diseases, 2019-11, Vol.69 (12), p.2185-2192

2019

Volltextzugriff (PDF)

A 24-Week Treatment Strategy With Pegylated Interferon/Ribavirin in HIV/Hepatitis C Virus Genotype 3–Coinfected Patients Who Achieved a Rapid Virologic Response Results in a High Sustained Virologic Response Rate

Clinical infectious diseases, 2014-01, Vol.58 (1), p.130-133

2014

Volltextzugriff (PDF)

Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial

Clinical infectious diseases, 2017-08, Vol.65 (4), p.551-556

2017

Volltextzugriff (PDF)

Efavirenz plasma concentrations and efficiency

AIDS (London), 2001-06, Vol.15 (9), p.1192-1193

2001

Volltextzugriff (PDF)

Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathy

AIDS (London), 2001-04, Vol.15 (6), p.809-809

2001

Volltextzugriff (PDF)

Antiretroviral Therapy in Early HIV Infection

The New England journal of medicine, 2016-01, Vol.374 (4), p.393

2016

Volltextzugriff (PDF)

Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapy

AIDS (London), 2014-01, Vol.28 (2), p.201-208

2014

Volltextzugriff (PDF)

Role of Ritonavir in the Drug Interactions Between Telaprevir and Ritonavir-Boosted Atazanavir

Clinical infectious diseases, 2014-01, Vol.58 (2), p.268-273

2014

Volltextzugriff (PDF)

The IL28B effect on hepatitis C virus kinetics among HIV patients after the first weeks of pegylated-interferon/ribavirin treatment varies according to hepatitis C virus-1 subtype

AIDS (London), 2013-07, Vol.27 (12), p.1941-1957

2013

Volltextzugriff (PDF)

Digital Necrosis Due to Leishmania Species Infection in a Patient with AIDS

Clinical infectious diseases, 1998-01, Vol.26 (1), p.198-199

1998

Volltextzugriff (PDF)

Simplified human immunodeficiency virus maintenance therapy in virologically suppressed children with Ritonavir-boosted protease inhibitor monotherapy

The Pediatric infectious disease journal, 2011-10, Vol.30 (10), p.917

2011

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Humans
(28)
Infectious Diseases
(24)
Immunology
(23)
Male
(22)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Adult
(19)
Female
(19)
Human Viral Diseases
(13)
Microbiology
(13)
Viral Diseases
(13)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(13)
Middle Aged
(12)
Virology
(12)
Hiv
(10)
Human Immunodeficiency Virus
(10)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(9)
Antiviral Agents
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus—Coinfected Patients With Compensated Cirrhosis

Natural History of Compensated Hepatitis C Virus-Related Cirrhosis in HIV-Infected Patients

Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients

Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy

Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients

Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus–Coinfected Patients With Compensated Liver Cirrhosis

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients

Response to: Reply to: Anti-CD4 autoantibodies in immunological nonresponder people living with HIV: cause of CD4+ T cell depletion?

Comparison of Two Methods for the Assessment of Delayed-Type Hypersensitivity Skin Responses in Patients with Human Immunodeficiency Virus Infection

Increased Regulatory T Cell Counts in HIV-Infected Nonresponders to Hepatitis B Virus Vaccine

Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program

Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients

Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial

Anti-CD4 autoantibodies in immunological nonresponder people with HIV: cause of CD4 + T-cell depletion?

High-risk Human Papilloma Virus Testing Improves Diagnostic Performance to Predict Moderate- to High-grade Anal Intraepithelial Neoplasia in Human Immunodeficiency Virus–infected Men Who Have Sex With Men in Low-to-Absent Cytological Abnormalities

A 24-Week Treatment Strategy With Pegylated Interferon/Ribavirin in HIV/Hepatitis C Virus Genotype 3–Coinfected Patients Who Achieved a Rapid Virologic Response Results in a High Sustained Virologic Response Rate

Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial

Efavirenz plasma concentrations and efficiency

Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathy

Antiretroviral Therapy in Early HIV Infection

Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapy

Role of Ritonavir in the Drug Interactions Between Telaprevir and Ritonavir-Boosted Atazanavir

The IL28B effect on hepatitis C virus kinetics among HIV patients after the first weeks of pegylated-interferon/ribavirin treatment varies according to hepatitis C virus-1 subtype

Digital Necrosis Due to Leishmania Species Infection in a Patient with AIDS

Simplified human immunodeficiency virus maintenance therapy in virologically suppressed children with Ritonavir-boosted protease inhibitor monotherapy

Aktive Filter

Suchergebnisse filtern